VREX

Varex Imaging Corp

The consensus price target hints at a 46.3% upside potential for VAREX IMAGING (VREX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

VAREX IMAGING (VREX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

VAREX IMAGING (VREX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

The average of price targets set by Wall Street analysts indicates a potential upside of 71.4% in VAREX IMAGING (VREX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

While the top- and bottom-line numbers for VAREX IMAGING (VREX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

VAREX IMAGING (VREX) delivered earnings and revenue surprises of +350.00% and +6.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

biote Corp. (BTMD) delivered earnings and revenue surprises of +66.67% and -1.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?